CV Sciences, Inc.
- Close
- Oct 5, 2026
- Market cap
- $2.36M
- 235.69M shares
- Filings
- 434
Q3 2026−12.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−38.8% FY25 yoy
- $2.36M
- —
- 0.2×
- 1.0×
- -8.02%
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 5, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $13,789,000 | reported | |
| FY 2024 | 2024-12-31 | $15,705,000 | reported | |
| FY 2023 | 2023-12-31 | $16,004,000 | reported | |
| FY 2022 | 2022-12-31 | $16,205,000 | reported | |
| FY 2021 | 2021-12-31 | $20,048,000 | reported | |
| FY 2020 | 2020-12-31 | $24,429,000 | reported | |
| FY 2019 | 2019-12-31 | $53,696,000 | reported | |
| FY 2018 | 2018-12-31 | $48,244,000 | reported | |
| FY 2017 | 2017-12-31 | $20,679,000 | reported | |
| FY 2016 | 2016-12-31 | $11,060,636 | reported | |
| FY 2015 | 2015-12-31 | $11,529,402 | reported | |
| FY 2014 | 2014-12-31 | $10,190,667 | reported |
Segments
Segments
LineFY2020ShareChange
Consumer Products Segment$24.43M100%−54.5%
Specialty Pharmaceutical Segment$0.00——
Total$24.43M
Pharmaceutical preparations
CV Sciences, Inc. is the 161st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IRDOpus Genetics, Inc.$14.2M29.1%349.3%$392.4MABUSArbutus Biopharma Corp$14.1M128.2%237.9%$617.8MPYXSPyxis Oncology, Inc.$13.9M14.2%574.5%$189.0M
CVSICV Sciences, Inc. (this company)$13.8M12.2%6.9%$2.4M
PTNPalatin Technologies Inc$13.2M—63.5%$12.2MTNXPTonix Pharmaceuticals Holding Corp.$13.1M29.8%946.2%$62.6MEVMNEvommune, Inc.$13.0M85.7%529.8%$241.9MEMMAEmmaus Life Sciences, Inc.$12.5M25.2%60.2%$4.2MPRLDPrelude Therapeutics Inc$12.1M73.4%819.6%$280.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR